Cholesterol and high-sensitivity C-reactive protein in acute coronary syndrome patients with early Simvastatin(胆固醇和高敏c反应蛋白在急性冠脉综合征患者早期辛伐他汀).doc

Cholesterol and high-sensitivity C-reactive protein in acute coronary syndrome patients with early Simvastatin(胆固醇和高敏c反应蛋白在急性冠脉综合征患者早期辛伐他汀).doc

  1. 1、本文档共14页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Cholesterol and high-sensitivity C-reactive protein in acute coronary syndrome patients with early Simvastatin(胆固醇和高敏c反应蛋白在急性冠脉综合征患者早期辛伐他汀)

Cholesterol and high-sensitivity C-reactive protein in acute coronary syndrome patients with early Simvastatin [Keywords] acute coronary syndrome [Abstract] Objective To observe the acute coronary syndrome (ACS patients with early simvastatin therapy on serum high-sensitivity C-reactive protein (hsCRP and lipid levels to explore the role of statins in ACS early intervention. Methods hospitalized patients with ACS 80 cases, a randomized, single-blind, controlled method ACS were divided into a control group (n = 38, the daily oral placebo and simvastatin treatment group (n = 42, simvastatin 20 mg / d, the onset of 48 h within start taking), the same two groups of other treatments, observed for four weeks, the concentration of serum hs-CRP and lipids were measured before and after treatment. hsCRP concentration using enzyme-linked immunosorbent assay, lipids using enzymatic 4 weeks of treatment results simvastatin group compared with the control group, serum hsCRP and total cholesterol (TC, triglycerides (TG and low-density lipoprotein cholesterol (LDLC) concentration was significantly lower (P lt;001, while the control group before and after treatment showed no significant (all Pgt; 0.05) Conclusion ACS patients early simvastatin therapy can significantly improve blood lipids, reduce hsCRP levels. simvastatin to decrease inflammation and plaque stabilization. [Keywords] acute coronary syndrome, C-reactive protein, lipids, simvastatin [Abstract] Objective to observe the effect of simvastatin on serum lipids and high sensitive Creactive protein (hsCRP) at the early stage in patients with acute coronary syndrome (ACS). Methods 80 hospitalized patients with ACS were selected and were randomly divided into control group (with placebo for 4 weeks, n = 38) and simvastatin group (with simvastatin 20mg per day, n = 42). Simvastatin and placebo were used within 48 hours from onset, and there were no other different therapeutic methods between two groups. The conce

您可能关注的文档

文档评论(0)

jiupshaieuk12 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档